<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04351672</url>
  </required_header>
  <id_info>
    <org_study_id>DFG RA 3340/3-1</org_study_id>
    <nct_id>NCT04351672</nct_id>
  </id_info>
  <brief_title>Time-restricted Feeding as a Dietary Strategy Against Metabolic Disturbances in Humans</brief_title>
  <acronym>ChronoFast</acronym>
  <official_title>Time-restricted Feeding as a Dietary Strategy Against Metabolic Disturbances in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>German Institute of Human Nutrition</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Immanuel Krankenhaus Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hasso-Plattner Institut, Potsdam, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Potsdam</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>German Institute of Human Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This human dietary intervention study with a cross-over design aims to compare the effects of
      two isocaloric diets - early time-restricted feeding (TRF) vs. late TRF - on glycemic control
      and lipid metabolism in overweight females with prediabetes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The participants are randomly allocated to one of two study groups: In study group (A)
      participants will begin with the early TRF (e-TRF) intervention. They will consume their
      habitual food (and the habitual daily amount of food) between 8 am and 4 pm for two weeks.
      After a washout-phase participants will conduct the late TRF (l-TRF) and consume their
      habitual food between 1 pm and 9 pm for another two weeks. Study group (B) receives the same
      interventions in the reversed order. Both dietary regimens will result in 8-hr eating period
      and 16-hr fasting period during the 24h day.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Anticipated">February 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>2 weeks</time_frame>
    <description>Assessed using Matsuda index in oral glucose tolerance test (OGTT)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glucose tolerance, fasting glucose, and overall daily glycemic variation</measure>
    <time_frame>1-2 weeks</time_frame>
    <description>Assessed by glucose area under the curve in OGTT and using a continuous glucose monitoring system</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic hormones and inflammatory markers</measure>
    <time_frame>2 weeks</time_frame>
    <description>Levels of hormones related to the glucose metabolism, hormones of appetite regulation, adipokines and inflammatory markers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood lipids</measure>
    <time_frame>2 weeks</time_frame>
    <description>Total cholesterol, low-density lipoprotein and high-density lipoprotein cholesterol and triglycerides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satiety and hunger scores</measure>
    <time_frame>2 weeks</time_frame>
    <description>Assessed using Visual Analog Scales (VAS with a scale of 1-100, where higher values correspond to stronger satiety/hunger)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep quality and duration</measure>
    <time_frame>1-2 weeks</time_frame>
    <description>Assessed by the Pittsburgh Sleep Quality Index (PSQI score, which ranges from 0-21, where higher values correspond to worse sleep quality) and also monitored by an ActiGraph device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>7 days</time_frame>
    <description>24-h physical activity will be monitored by an ActiGraph device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of metabolic genes in adipose tissue</measure>
    <time_frame>2 weeks</time_frame>
    <description>RNA-Seq analysis of subcutaneous adipose tissue samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Social and economic decision behaviour</measure>
    <time_frame>2 weeks</time_frame>
    <description>Assessed by computer tests together with the Barratt Impulsiveness Scale short version (BIS-15 with a score between 15 and 60, where higher values correspond to higher impulsiveness) and the UCLA Loneliness Scale (with a score between 20 and 100, where higher values correspond to higher subjectively perceived loneliness)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>PreDiabetes</condition>
  <condition>Overweight and Obesity</condition>
  <arm_group>
    <arm_group_label>Early Time-Restricted Feeding</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Late Time-Restricted Feeding</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Early Time-Restricted Feeding</intervention_name>
    <description>Eat between 8 am and 4 pm for two weeks</description>
    <arm_group_label>Early Time-Restricted Feeding</arm_group_label>
    <other_name>Early TRF</other_name>
    <other_name>eTRF</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Late Time-Restricted Feeding</intervention_name>
    <description>Eat between 1 pm and 9 pm for two weeks</description>
    <arm_group_label>Late Time-Restricted Feeding</arm_group_label>
    <other_name>Late TRF</other_name>
    <other_name>lTRF</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI 25-35 kg/mÂ²

          -  Prediabetic as determined by fasting glucose 100-120 mg/dl and/or 2h glucose 140-200
             mg/dl in OGTT

        Exclusion Criteria:

          -  prior diagnosis of type 1 or 2 diabetes

          -  weight changes &gt; 5% within past 3 months

          -  current shift work or history of shift work

          -  traveled across more than one time zone one month before the study

          -  poor quality of sleep (PSQI score&lt;10)

          -  eating disorders, food intolerance/allergy, severe indigestion

          -  Pregnant or breastfeeding

          -  severe internal or psychiatric disorders or other conditions that might influence the
             outcome of the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Olga Ramich, PD Dr.</last_name>
    <phone>+4933200882749</phone>
    <email>olga.ramich@dife.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>German Institute of Human Nutrition Potsdam-Rehbruecke</name>
      <address>
        <city>Nuthetal</city>
        <zip>14558</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olga Ramich, PD Dr.</last_name>
      <email>olga.ramich@dife.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 7, 2020</study_first_submitted>
  <study_first_submitted_qc>April 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2020</study_first_posted>
  <last_update_submitted>April 15, 2020</last_update_submitted>
  <last_update_submitted_qc>April 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>German Institute of Human Nutrition</investigator_affiliation>
    <investigator_full_name>Olga Ramich (formerly Pivovarova)</investigator_full_name>
    <investigator_title>project director</investigator_title>
  </responsible_party>
  <keyword>Time-restricted feeding</keyword>
  <keyword>Meal timing</keyword>
  <keyword>Obesity</keyword>
  <keyword>Prediabetes</keyword>
  <keyword>Glycemic control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

